TAT(SZ:002433)2017-10-24 16:00Financial Performance - Operating revenue decreased by 18.30% to CNY 636,591,145.94 for the current period, while year-to-date revenue increased by 2.36% to CNY 2,214,607,118.50[7] - Net profit attributable to shareholders increased by 17.56% to CNY 91,862,612.16 for the current period, and year-to-date net profit rose by 25.11% to CNY 205,461,839.23[7] - Basic earnings per share rose by 20.00% to CNY 0.12 for the current period, with a year-to-date increase of 28.57% to CNY 0.27[7] - Operating profit increased by CNY 59.86 million, a growth of 34.39%, driven by higher sales revenue and improved product mix[17] - The company reported a total profit of CNY 108,485,890.49 for the third quarter, an increase from CNY 92,549,268.48, marking a growth of approximately 17.2%[43] - The net profit for the third quarter of 2017 reached CNY 93,094,199.94, compared to CNY 80,877,638.18 in the previous year, reflecting a year-over-year increase of about 15.5%[43] - The total profit for the third quarter was CNY 248,665,464.80, an increase of 28.4% compared to CNY 193,676,190.12 in the previous year[52] Cash Flow - Net cash flow from operating activities increased significantly by 139.93% to CNY 41,119,709.04 for the current period[7] - Net cash flow from operating activities was -306,480,811.77 CNY, compared to -496,898,673.29 CNY in the previous period, showing an improvement of approximately 38.3%[60] - Total cash inflow from operating activities reached 2,043,681,839.06 CNY, significantly up from 584,713,495.04 CNY, marking an increase of about 249.5%[60] - Cash outflow from operating activities totaled 2,350,162,650.83 CNY, compared to 1,081,612,168.33 CNY in the previous period, representing an increase of approximately 117.5%[60] - The net cash flow from financing activities was 690,880,018.56 CNY, compared to 624,941,732.33 CNY in the previous period, indicating an increase of about 10.5%[61] Assets and Liabilities - Total assets increased by 15.58% to CNY 7,950,704,919.50 compared to the end of the previous year[7] - Total liabilities were CNY 3,025,722,532.40, up from CNY 2,137,051,184.67[36] - Current liabilities increased to CNY 1,826,827,764.93 from CNY 1,045,223,589.29[36] - Non-current assets totaled CNY 3,789,143,696.31, an increase from CNY 2,838,062,510.97[36] - Cash and cash equivalents decreased to CNY 130,580,719.74 from CNY 185,883,316.91[38] Investments and Expenditures - Cash outflow from investment activities increased by CNY 736.25 million, a growth of 282.72%, primarily due to investments in new facilities and properties[21] - The company reported a total cash outflow of 996,666,403.01 CNY from investment activities, compared to 260,413,575.63 CNY in the previous period, reflecting a significant increase of approximately 282.5%[59] - Construction in progress increased by 159.13% to CNY 423,015,132.43, driven by payments for ongoing projects[15] Receivables and Payables - Accounts receivable increased by 39.56% to CNY 21,169,814.11, attributed to an increase in bank acceptance bills from distributors[15] - Prepayments rose by 51.87% to CNY 89,134,394.11, mainly due to increased advance payments for renovations, equipment, and herbal medicine procurement[15] - Accounts receivable stood at 454.03 million RMB, slightly down from 462.38 million RMB, suggesting stable collection performance[34] Compliance and Commitments - The company has committed to distributing cash dividends amounting to no less than 30% of the average distributable profit over the next three years, contingent on no major capital expenditures or restructuring plans[25] - The company has maintained compliance with its commitments regarding non-competition and related party transactions, with ongoing fulfillment of these commitments since 2008[24] - The company has not reported any non-compliance issues regarding external guarantees during the reporting period[28] - There were no non-operating fund occupations by controlling shareholders or related parties during the reporting period[29]